Evidence map›Paper›PMID 40807436›Full record

ReviewMolecules (Basel, Switzerland)2025

From Nutrition to Innovation: Biomedical Applications of Egg Components.

Amin Mohseni Ghalehghazi, Wen Zhong

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amin Mohseni GhalehghaziDepartment of Biosystems Engineering, University of Manitoba, Winnipeg, MB R3P 0W8, Canada.ORCID 0009-0005-8110-2782
Wen ZhongDepartment of Biosystems Engineering, University of Manitoba, Winnipeg, MB R3P 0W8, Canada.ORCID 0000-0002-7957-7237

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valued for their nutritional content, eggs have recently gained attention as a versatile biomaterial owing to their biocompatibility, biodegradability, and unique structural and biochemical composition. This review highlights the biomedical potential of various egg components-eggshell, eggshell membrane, egg white, and egg yolk-and their applications in bone grafting, tissue engineering, wound healing, drug delivery, and biosensors. Eggshells serve as a natural, calcium-rich source for bone tissue engineering and regenerative medicine. The eggshell membrane, with its antimicrobial and structural properties, offers promise as a wound healing scaffold. Egg white, known for its gelation and film-forming capabilities, is utilized in hydrogel-based systems for drug delivery and biosensing. Egg yolk, rich in lipids and immunoglobulin Y (IgY) antibodies, is being explored for diagnostic and therapeutic applications. This review critically examines the advantages and limitations of each egg-derived component and outlines current research gaps, offering insights into future directions for the development of egg-based biomaterials in biomedical engineering.

Indexed as

Biocompatible MaterialsEggsEgg ShellAnimalsBiosensing TechniquesDrug Delivery SystemsEgg WhiteEgg YolkHumansRegenerative MedicineTissue EngineeringWound HealingBiocompatible Materialsbiomaterialsbiomedical applicationsegg

Identifiers

PMID40807436
PMCPMC12348192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.